Clinical trial
Gene Therapy for Alpha 1- Antitrypsin Deficiency
NCT06996756 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gene Therapy for Alpha 1- Antitrypsin Deficiency
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- February 26, 2025
- Completion date
- August 1, 2032
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.